Developing novel serosurveillance tools to monitor declining infection in the malaria elimination age

Speaker

Abstract

Background and aim:
Worldwide malaria cases have declined. However, despite recent advances, resistance to front line drugs and insecticides means the burden remains high (219 million cases in 2017). The World Health Organisation’s (WHO) Global Technical Strategy (GTS) milestone for 2020 was to eliminate  malaria from 10 countries. One of the three main aims towards achieving this was to “Transform malaria surveillance into a core intervention”. However, declining malaria also means increasing difficulty in detecting infections. Therefore, as countries approach elimination, additional measures are required to improve the sensitivity of surveillance. Antibodies are a sensitive marker of exposure that are acquired after each infection and lost over time. By focusing on markers of recent exposure, we have developed a serosurveillance panel and a prototype lateral flow device to help contribute to malaria elimination efforts.

Methods:
We have developed a number of novel malaria species-specific recombinant antigens and coupled these to MagPlex® Microspheres, or “beads”, to develop a novel multiplex serology assay. Using the MAGPIX® platform, we have screened serum samples or eluted dried blood spots to determine prevalence of exposure.

Results:
We have generated a rich dataset from malaria-endemic regions spanning a wide geographical range and contrasting endemicities, totaling >35,000 serum samples (and dried blood spots) since 2017. In addition, we have established the MAGPIX® platforms in most of these sites to aid sample access and knowledge transfer.

Conclusion:
Using the MAGPIX® platform, we have developed a unique panel of reagents to help detect exposure to three of the main causes of human malaria, Plasmodium falciparum, P.vivax and P.knowlesi.


Show Resources
You May Also Like
SEP 28, 2022 9:00 AM PDT
SEP 28, 2022 9:00 AM PDT
Date: September 28, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) While COVID-19 continues to be the most pressing diagnostic focus for clinical laboratories, HIV remains a serious g...
OCT 12, 2022 8:00 AM PDT
OCT 12, 2022 8:00 AM PDT
First Broadcast: Date: October 12, 2022 Time: 8:00am PDT, 11:00am EDT Second Broadcast: Date: October 12, 2022 Time: 9:00am SGT The new Embedded CryoSPARC Live, now fully integrated with t...
AUG 10, 2022 10:00 AM PDT
AUG 10, 2022 10:00 AM PDT
Date: August 10, 2022 Time: 10:00am PDT, 1:00pm EDT The global pandemic has increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provid...
JUN 29, 2022 8:00 AM PDT
JUN 29, 2022 8:00 AM PDT
Date: June 29, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) As of May 2022, there have been more than 500 million confirmed cases of COVID-19, including numerous variants. Additiona...
NOV 09, 2022 8:00 AM PST
NOV 09, 2022 8:00 AM PST
Date: November 09, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) The field of cell and gene therapy is rapidly growing. In particular, the use of lentiviruses in CAR-T applications is...
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...

Developing novel serosurveillance tools to monitor declining infection in the malaria elimination age



Show Resources
Loading Comments...
Show Resources
Attendees